))
Breastfeeding Helps Childhood Cancer Survivors, Oil Pill Greatly Reduces PMS Symptoms, Scientists Come Closer to MRSA Vaccine (Video)
Archived series ("Inactive feed" status)
When?
This feed was archived on August 21, 2018 02:49 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 156751857 series 1198360
Content provided by Insidermedicine Daily News (Audio). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Insidermedicine Daily News (Audio) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
(January 21, 2011 - Insidermedicine)
From Tennessee - A new report published in Journal of Cancer Suvivorship recommends that women who have survived childhood cancer breast-feed their children. Reviewing several studies, researchers found that breast-feeding helped to offset the many long-term side effects of cancer treatment such as heart disease and secondary tumors.
From Brazil - An essential oil pill can greatly reduce symptoms of PMS, according to a report published in Reproductive Health. Studying 120 women, researchers found that an essential oil pill containing gamma linolenic acid, oleic acid, linoleic acid, other polyunsaturated acids and vitamin E significantly reduced PMS symptoms. (Federal University of Pernambuco, lifted)
And finally, from Rochester - Scientists may be closer to developing a vaccine for MRSA, according to research presented at the Orthopaedic Research Society annual meeting. Researchers injected mice with four anti-glucosaminidase antibodies and then exposed the rodents to MRSA. Results showed that only half of the mice developed MRSA, a sign of great progress against the deadly infection.
1297 episodes
Share
